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Abstract
Background: Kaposi’s sarcoma associated herpesvirus (KSHV/HHV-8) is the causal agent of all forms of Kaposi sarcoma.
Molecular epidemiology of the variable K1 region identified five major subtypes exhibiting a clear geographical
clustering. The present study is designed to gain new insights into the KSHV epidemiology and genetic diversity in
Cameroon.
Methodology/Principal Findings: Bantu and Pygmy populations from remote rural villages were studied. Antibodies
directed against latent nuclear antigens (LANA) were detected by indirect immunofluorescence using BC3 cells. Peripheral
blood cell DNAs were subjected to a nested PCR amplifying a 737 bp K1 gene fragment. Consensus sequences were
phylogenetically analyzed. We studied 2,063 persons (967 females, 1,096 males, mean age 39 years), either Bantus (1,276) or
Pygmies (787). The Bantu group was older (42 versus 35 years: P,1024). KSHV anti-LANA seroprevalence was of 37.2% (768/
2063), with a significant increase with age (P,1024) but no difference according to sex. Seroprevalence, as well as the anti-
LANA antibodies titres, were higher in Bantus (43.2%) than in Pygmies (27.6%) (P,1024), independently of age. We
generated 29 K1 sequences, comprising 24 Bantus and five Pygmies. These sequences belonged to A5 (24 cases) or B (five
cases) subtypes. They exhibited neither geographical nor ethnic aggregation. A5 strains showed a wide genetic diversity
while the B strains were more homogenous and belonged to the B1 subgroup.
Conclusion: These data demonstrate high KSHV seroprevalence in the two major populations living in Southern and Eastern
Cameroon with presence of mostly genetically diverse A5 but also B K1 subtypes.
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Introduction
Human herpesvirus-8 (HHV-8) or Kaposi’s sarcoma associated
herpesvirus (KSHV) is a Gammaherpesvirus, first identified in a tumor
biopsy from an AIDS-related Kaposi’s sarcoma (KS) [1]. It is
considered as the causing agent of all forms of KS [2,3,4] (epidemic,
iatrogenic, classic and endemic) as well as Primary Effusion
Lymphoma [5,6], andmostMulticentric Castleman Diseases [7,8,9].
KSHV global distribution is heterogeneous. Areas of high en-
demicity, corresponding to areas of classic and endemic KS have
been reported [10,11,12,13,14,15]. The epidemiological determi-
nants are quite different depending on the level of endemicity
[3,12,13,14,15,16,17,18,19,20]. Saliva is considered as the main
vector of KSHV infection [13,21,22]. Interestingly, KSHV
infection can be unevenly distributed from one region to another
[14,19,23,24,25,26,27] suggesting non-uniform specificities in
transmission modes [28,29].
Molecular epidemiology studies on KSHV have mainly focused
on the variable K1 region (ORF-K1). This has lead to the
identification of five main viral subtypes (A, B, C, D, E) that exhibit
a geographical clustering [30,31,32,33,34,35,36,37,38,39,40].
There are two highly variable K1 regions (VR1 and VR2), which
encode the areas usually targeted by the immune system on the K1
protein [30,41]. Subgroup A1–4 and subtype C are predominant
among populations of European descent [30,32,36,42,43] and in
some regions of Asia [44,45,46]. Subgroup B1–4 and clade A5 are
predominant in Sub-Saharan Africa [31,34,35,47,48,49,50]. The
present work aimed at gaining new insights into the KSHV
epidemiology and genetic diversity in Cameroon, in Western
Central Africa. Although endemic and epidemic KS are
frequent in Cameroon, KSHV genetic polymorphism is nearly
unknown in this country with only three K1 sequences published
so far [34].
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Methods
Ethics statement
Ethical approval was given in Cameroon by the Ministry of
Public Health in Cameroon: D30-295/AR/MINSANTE/SG/
DROS/CRC/CEA1, the National Comity of Ethics in Camer-
oon: Nu 034/CNE/MP/06. In France by the Comite´ de
Protection des Personnes (CPP): 2011/01NICB, the Commission
Nationale pour l’Informatique et les Liberte´s (CNIL): EGY/FLR/
AR111711. Prior to field sampling, community and individual
written informed consent were sought and provided by partici-
pants after detailed information on the study were provided.
Geographic and demographic data
This study was carried out in rural areas of Cameroon (figure 1).
The present study was performed on a large population of Bantus
and Pygmies, living in remote rural villages or settlements of the
rain forest area of South and East Cameroon. Study populations
were sequentially sampled over different time periods. Samples
from the South were mostly collected from 1994 through 2000. A
complementary series was collected from 2006 through 2010.
Samples from the Centre and the East areas were collected from
2004 through 2010. Populations and collection procedures have
been previously described [51,52] and comprise diverse Bantu
groups from the three study areas and two Pygmy groups. The
Baka Pygmies, by far the most important Pygmy group in
Cameroon is found in Eastern and Southern Cameroon. The
Bakolas are the second most important group and have their
settlements exclusively in the Southern part of the country and the
Bedzams are the less numerically important and less accessible.
This group was not included in the current work. A systematic
approach for the enrolment was carried out in all reachable
villages and settlements, scattered alongside roads and tracks
across the forest. A standardized questionnaire was used to collect
personal demographic data. Collected data included the name,
age, sex, location, ethnicity, family links. A 5 to 10 ml whole blood
sample was collected in EDTA K2 vacuum tubes, from all
consenting individuals meeting the inclusion criteria. Plasma and
buffy-coat were obtained 48 to 72 hours after sampling and kept
frozen at 280uC.
A simple clinical examination was performed when requested
by participants in the study. Treatment for common local ailments
was given if available. A transfer to an appropriate medical facility
was advised for severely ill individuals encountered on site.
Ethical approval
The Ministry of Public Health and the National Comity of
Ethics approved the study in Cameroon. In France, approval was
obtained from the ‘‘CPP’’ and the ‘‘CNIL’’. Prior to field
sampling, community and individual written informed consent
were sought and provided by participants after detailed informa-
tion on the study were provided.
KSHV serologic tests
Serologic detection of anti-LANA antibodies was done by
indirect fluorescent assay using KSHV positive and EBV negative
BC3 cell line expressing only Latent-associated Nuclear Antigen as
described, [37,53] using diluted plasma (1:40, 1:80, 1:160)
deposited on BC3 cells. Positivity was considered for presence of
nuclear dotted reactivity at 1:80 dilution.
Statistical methods
Statistical analyses were realized with ‘‘Stata’’ software version
11.1 (Statacorp, Colledge Station, Texas). Between groups
characteristics were compared using the Student t test for
continuous variables and the Fisher exact test for categorical
variables. Adjustment for age was performed using a logistic
regression model for KHSV prevalence, and a linear regression
model for log-transformed titers. Test for trends were used to study
changes of KHSV prevalence or antibody titres over age.
KSHV molecular analysis and phylogenetic analyses
Conditions and procedures for DNA extraction from blood
buffy coats in all positive plasmas on BC3 serological assays, as
well as amplification method have been previously described [37].
Amplified products for 29 samples were directly sequenced and
phylogenetic analyses were conducted.
All new sequences are deposited in GenBank under accession
numbers: JX290272 (O350805), JX290273 (Mezi5), JX290274
(AKO107), JX290275 (Lobak80), JX290276 (Mezi1), JX290277
(Ako381), JX290278 (BAD54), JX290279 (BAD84), JX290280
(BAD230), JX290281 (BAD337), JX290282 (CHAS59), JX290283
(CHAS80), JX290284 (Lobak42), JX290285 (lozi5), JX290286
(Lozi6), JX290287 (MEBAK55), JX290288 (MEZI8), JX290289
(MEZI11), JX290290 (O290107), JX290291 (AKO205),
JX290292 (O300153), JX290293 (O300186), JX290294
(O300189), JX290295 (O300137), JX290296 (O300227),
JX290297 (O300237), JX290298 (O300265), JX290299
(O300275), JX290300 (O323101).
Analysis of recombination events
The recombinant analysis was performed by boot scanning with
the Simplot software v3.5.1 [54].
Nucleotide sequence accession numbers
We deposited all 29 new nucleotide sequences in GenBank
under accession numbers JX290272 to JX290300.
Results
KSHV sero-epidemiology in the studied populations
The current study tested 2063 individuals (967 females, 1096
males) originating from rural areas of the Center, the South and
Author Summary
Kaposi’s sarcoma associated herpesvirus (KSHV/HHV-8) is
the causal agent of one of the most frequent skin tumors
found endemically or epidemically associated to HIV in
Central and Eastern Africa. This highly variable virus tends
to cluster geographically according to specific major
subtypes. Its prevalence is high in that area and increases
with age. Despite its association to all forms of Kaposi
sarcoma and high prevalence described in some low
income populations in Cameroon, KSHV arouses limited
interest, and only few focused previous studies have
looked into prevalence and modes of transmission,
especially in families. Extended molecular epidemiology
is unknown both in healthy individuals and in Kaposi
patients, which led to looking for new insights among
Bantu and Pygmy populations from rural villages in three
regions of Cameroon sharing a quite similar living
environment but yet genetically, socially, and culturally
different. The present study is designed to describe
variations of molecular subtypes in each of these popu-
lation groups regarding their geography in rural areas of
southern, central, and eastern Cameroon.
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the East regions of Cameroon (table 1). Of note, no Pygmies
populations were studied from the Center area. The mean and
median age for the overall population was 39 years; however, the
mean age of Pygmies was 35.4 years, and it was higher in Bantus
(41.5 years, p,1024) (table 1). The overall KSHV sero-prevalence
in the study was high (37.2%, 768/2063) and significantly
increased with age (p,1024), but was not different according to
sex, (37.6% (413/1096) in males and 36.7% (355/967) in females
(p = 0.68). KSHV prevalence in Bantus (43.2%, 551/1276) and in
Pygmies (27.6%, 217/787) was significantly different (p,1024).
While the KSHV prevalence increased with age among Pygmies
(p = 0.001), the increase was less pronounced among Bantus
(p = 0.04) (figure 2).
Anti-LANA-1 antibody titres were globally high in infected
people and ranged from 80 (1.9 log) to 20,480 (4.3 log) with a
geometric mean value of 2.6 log. Significantly higher anti-LANA-
1 titres were found in infected Bantus compared to infected
Pygmies (geometric means of 2.7 versus 2.4 log, respectively, p,
1025), and this difference was independent of age. In a
multivariate analysis, we observed higher anti-LANA1 titres in
Bantus p,1024 in the South and the East regions compared to the
Center (p,1024).
Overall variability
DNAs extracted from peripheral blood buffy-coats from 461
persons including 56 living in the Center, 190 in the South and
215 in the East were all amplifiable by the b-globin PCR and then
subjected to KSHV K1 PCR. Finally, 29 sequences (29/461= 6%)
of 730 bp of the K1 gene (ORF-K1) were generated from 18 men
and 11 women (median age = 35 years and range 6–75 years). All
sequences originated from apparently healthy individuals (24
Bantus and 5 Pygmies). Twenty-seven sequences were unique. The
isolates from two couples were found identical. Five of the
sequences were of the B subtype while 24 were of the A5
subgroup. Intratype and intertype polymorphism were observed
among the 29 new K1 sequences. Pairwise comparison of the 27
unique sequences revealed an overall intertype nucleotide
polymorphism of up to 20% and a 37.5% amino acid polymor-
phism. The 22 unique A5 sequences exhibited a 0.2% to 6.9%
nucleotide divergence while the five unique subtype B sequences
showed a 0.3% to 6.6% divergence in their nucleotides
composition.
Phylogenetic analyses
The initial phylogenetic analyses were performed on 633 nt-
long sequences, including the 29 new strains, together with 61 K1
prototype sequences. The analyses were based upon 2 different
phylogenetic methods (neighbor joining and maximum likelihood),
which gave similar phylogenetic topologies. The 5 major K1
molecular subtypes (A, B, C, D, E) were supported by high
bootstrap values in the NJ analysis (figure 3). The 29 new strains
did segregate in the 2 separate groups, previously described as sub-
Saharan taxa. Most of the strains (24/29= 83%) belonged to the
paraphyletic A5 clade, which contains also the 3 Cameroonian
sequences previously obtained from AIDS-KS [34]. The remain-
ing sequences (5/29= 17%) clustered with the B1 subgroup, with
sequences originating from Central African Republic, Uganda and
Zimbabwe.
Interestingly, the 29 new sequences exhibited neither geograph-
ical nor ethnic group aggregation. Indeed, 4 out of the 5 strains
originating from Pygmies belonged to the A5 clade. The
proportion was the same for the Bantus strains (20/24= 83%).
We also performed phylogenetic studies separately on the
sequences encoding the variable regions (VR, 258 nt-long
Figure 1. Geographical distribution of KSHV seroprevalence in studied areas of South Cameroon. Rural study areas are shadowed
orange in the Center, purple in the South and blue in the East. Nature reserves are shown green stripped areas in the East (Dja) and in the South
(Campo). Grey shadowed ellipses show general regional ethnic KSHV prevalence which is higher among Bantus than Pygmies.
doi:10.1371/journal.pntd.0002851.g001
HHV-8/KSHV in Pygmies and Bantus in Cameroon
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sequences), which are the major target of the immune system
[30,41] and the rest of the sequence, that is less susceptible to the
immune system as an evolutionary driving force (375 nt). With
both subsets, the 5 major subtypes could be defined (figure 4). We
confirmed that the 29 new K1 sequences did segregate in 2 groups:
one belonging to the A subtype and the other one to the B subtype.
Of note, the definition of the A1–4 monophyletic group was
possible when analyzing the VR regions: a high boostrap value
was found at the root of the group. Interestingly, such a group was
not distinguishable when considering the rest of the sequence: one
could not differentiate the strains from this clade from sequences of
the A5 group.
Discussion
Cameroon is a Central African country where KSHV and KS
are highly prevalent [14,19,49,55,56,57]. However, the previous
works were focused on specific populations/regions, restricted only
to sero-epidemiology and performed on relatively small sample
[19,55,56,57]. In contrast, in our study, performed on more than
2000 individuals, we have included the two major and very
different populations living in rural South Cameroon: the Bantus
and the Pygmies. Moreover, we have also performed a molecular
epidemiological work aimed at studying the genetic diversity of
KSHV strains in these populations of different origins [58].
Sero-epidemiology
The present epidemiological report shows a very high KSHV
seroprevalence in the two rural populations studied. This confirms
previous findings on a smaller population of rural Bantus from
South Cameroon [19] and extends it to Bantus living in other
areas, as well as, for the first time to the remote Pygmy
populations.
Furthermore, our study demonstrated that KSHV is highly
prevalent in children. This is consistent with a non-sexual
acquisition of the virus. Indeed, in highly endemic population of
African origin, studies have demonstrated a high level of familial
aggregation, with transmission between children of the same
family and from mother to child [19,20]. In central, and mostly
East Africa, endemic KS can also occur in young children. We
previously hypothesized that this peculiar KS form may be related
to an early and massive KSHV infection in genetically susceptible
individuals [14]. In some classical KS in children, diverse genetic
defects have been reported [59,60,61]. Similar studies need to be
performed in children suffering from endemic KS in central
Africa.
We found that KSHV prevalence was similar in men and
women in both groups and increased with age, especially in Pygmy
groups. This is comparable to the data found on rural general
populations of central and East Africa [14,19,49,55,57,62]. While
in African population, non-sexual transmission of KSHV is
considered as the major mode of viral acquisition, sexual
transmission is likely to contribute to further viral spread in adults
[3,13,63]. However, this feature appears to greatly differ to that of
industrialized/occidental countries where most of the infection
seems to be acquired after adolescence, especially in high-risk
groups [3,63,64].
KSHV seroprevalence was quite surprisingly found higher in
Bantus than in Pygmies. Indeed, we expected a higher prevalence
in Pygmies as they have a lower ‘‘living standard’’ than the
surroundings Bantus. As demonstrated for EBV, studies have
indeed suggested that KSHV prevalence, in Africa, may also be
related to the socio-economic level of the studied populations
[65,66]. Furthermore, other works show that populations that kept
a traditional way of life show high prevalence for KSHV
[13,33,67]. However, other studies are necessary to appreciate
the different items (environmental co-factors, specificities in ways
of life influencing transmission modes, or even genetic features),
which can lead to the apparent differences found here between
Pygmies and Bantus.
Our present sero-epidemiological report was based on anti-
LANA-1 antibodies detection while several of the performed
studies in Africa used assays detecting anti-lytic antibodies. While
both assays perform very well in epidemiological studies, the latter
are generally considered less specific than the anti-latent ones
[3,13,68,69]. This implies that seroprevalences are frequently
lower in studies using anti-latent assays [69,70,71,72]. This is well
illustrated by a work performed in 292 persons from a North
Cameroon hospital using anti-latent or anti-lytic immunofluores-
cence assays (IFA). While the anti-lytic IFA prevalence was 51%
with a clear increase with age, the anti-latent IFA prevalence was
of 25% without any increase with age [55].
Figure 2. KSHV Seroprevalence in Bantus and Pygmies by immunofluorescent assay. The Immunofluorescent detection assay on BC3 cells
considered a 1:80 positivity threshold for anti-LANA-1 antibodies. The graph displays the prevalence (Y axis) according to age categories (X axis). A
significant increase with age has been observed in Pygmies (dark green) but less visible in Bantus (light grey).
doi:10.1371/journal.pntd.0002851.g002
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Our study may have some limitations. HHV-8 between-group
prevalence difference is generalized and assumed to Bantus and
Bedzams in the Centre area despite no data were available from
the Bedzam Pygmies.
Molecular epidemiology and possible origins of the A5
clade
We have shown here that the 29 obtained KSHV K1 sequences
(5 from Pygmies and 24 from Bantus) are all sub-Saharan A5 or B
variants. In our report, we did not observe any specific
geographical or ethnical subtype or subgroup segregation. Both
Bantus and Pygmies were represented in A5, and B1 subgroups
that appear to be distributed throughout the studied areas. This
suggests an ancient origin of these strains in these areas and a
genetic exchange between both populations. Of note, the
prevalence of A5 sequences in our study is higher than prevalence
observed in Zimbabwe (45% of 64 KS patients) [50], in Uganda
(53% of 31 KS patients) [73], in West and other Central African
countries (8 of 21 KS patients) [34].
Interestingly, the B monophyletic group is, so far, composed
exclusively of sequences isolated from individuals with African
origins, suggesting a geographical isolation of the infected
Figure 3. Phylogenetic relationships between the 27 unique new KSHV/HHV-8 sequences. The phylogenetic tree includes the 29 new
633 bp KSHV K1 consensus sequences and worldwide A to E sub-types prototypes from healthy persons and KS patients. Amplification was done
with primers K1AG75s: GACCTTGTTGGACATCCCGTACAATC, K1AG1200as: AGGCCATGCTGTAAGTAGCACGGTT for the outter fragment and VR1s:
ATCCTTGCCAAYATCCTGGTATTGBAA and VR2 as1: AGTACCAMTCCACTGGTTGYGTAT for the inner fragment. Amplified products for 29 samples were
directly sequenced. Once the sequences obtained, a multiple sequence alignment was performed with the DAMBE program (v.4.2.13) on the basis of
a previous amino acid alignment created from the original sequences. The final alignment was submitted to the Modeltest program (v.3.6) to select
the best evolutionary model, according to the Akaike Information Criterion, to apply for the phylogenetic analyses. The phylogeny was derived by
both the neighbor-joining (NJ) and maximum parsimony (MP) method, performed in the PAUP program (v.4.0b10) (Sinauer Associates, Sunderland,
MA, USA) and the reliability of the inferred tree was evaluated by bootstrap analysis on 1000 replicates. New A5 sequences are shown in bulk red and
B sequences are in bulk blue. The tree is drawn to scale with 0.1 nucleotide replacements per site.
doi:10.1371/journal.pntd.0002851.g003
Figure 4. Phylogenetic analyses between the colinearized encoding variable region VR1 and VR2 fragments (258 nt) on panel A
versus the rest of the sequence (375 nt) on panel B of the 29 new KSHV/HHV-8 strains from Cameroon with 22 representative KSHV/
HHV-8 strains from A/C subtypes. Panel A shows the results from the 258 nt-long sequences for the highly variable regions VR1 and VR2. Panel B
shows the results for the 375 nt-long sequence from the rest of the sequence that is less susceptible to the immune system as an evolutionary driving
force.
doi:10.1371/journal.pntd.0002851.g004
HHV-8/KSHV in Pygmies and Bantus in Cameroon
PLOS Neglected Tropical Diseases | www.plosntds.org 7 May 2014 | Volume 8 | Issue 5 | e2851
populations and an ancient speciation. In contrast, the African
sequences from the A5 paraphyletic group are closely related to
viruses found mostly in populations, which form the A1–4
subgroup. The origin of the A5 group is thus quite intriguing.
We first envisioned that the A5 clade could have emerged upon
recombination, and would therefore form an intermediate group.
However, by Simplot analysis, we found no evidence for such a
genetic event. Therefore, we speculate that the divergence between
the A1–4 and A5 groups rose from natural genetic drift and
speciation. It would have been very interesting to date the separation
of the viral populations. Unfortunately, the molecular clock analysis
we performed was not conclusive. Indeed, to perform such study,
one would like to focus on segments that have comparable mutation
rates. Usually, when considering coding regions, we focus on the
divergence of the 3rd nucleotide codon. Considering this limitation,
the sequence we considered was too short, not informative enough.
Thus, we studied separately the two VR genetic regions, which
are the major targets of the immune system on K1, and the rest of
the sequence. When considering the VR genetic regions, the A5
and A1–4 subgroups were still defined. In contrast, these groups
were undistinguishable when considering the rest of the sequence.
These data suggest that the separation between the 2 groups is not
ancient enough to have accumulated mutation through genetic
drift on the entire sequence; the separation between the A1–4 and
A5 groups is thus, probably, more recent than the emergence of
the C or B subgroups. This conclusion was previously suggested.
Indeed, White et al. have shown that viral strains from the B
subtype have accumulated more non-synonymous mutations when
compared to strains from the A5 group, which they interpreted as
the hallmarks of an older divergence of the B subtype [50]. This
conclusion is strengthened by the fact that non-synonymous
mutations were observed throughout the B strains sequences,
while they were limited to the VR regions for the A5 clade. This
suggests that the immune pressure for the 2 groups could have
been different. The difference between the A1–4 and A5 group is
suspected to be mainly shaped upon immune pressure on the VR
regions. As for the origins of the A5 group, we hypothesize that the
A group has African origins and upon immune selection (maybe
associated with specific HLA) a monophyletic A1–4 group has
emerged, mostly in Caucasian populations, but also described in
individuals of African origin [30]. The remaining sequences would
then form the A5 clade.
Cameroon is a good candidate for further phylo-geographic
studies of KSHV subtype distribution and polymorphism as the
country is inhabited by a multitude of ethnic groups of divergent
historical origins.
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